McArdle L - Search Results

1

Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastoma.

Stallings RL, Carty P, McArdle L, Mullarkey M, McDermott M, Breatnach F, O'Meara A. Stallings RL, et al. Among authors: mcardle l. Cancer Genet Cytogenet. 2004 Oct 1;154(1):44-51. doi: 10.1016/j.cancergencyto.2004.04.003. Cancer Genet Cytogenet. 2004. PMID: 15381371

2

Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.

McArdle L, McDermott M, Purcell R, Grehan D, O'Meara A, Breatnach F, Catchpoole D, Culhane AC, Jeffery I, Gallagher WM, Stallings RL. McArdle L, et al. Carcinogenesis. 2004 Sep;25(9):1599-609. doi: 10.1093/carcin/bgh173. Epub 2004 Apr 16. Carcinogenesis. 2004. PMID: 15090470 Review.

3

Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.

Stallings RL, Carty P, McArdle L, Mullarkey M, McDermott M, O'Meara A, Ryan E, Catchpoole D, Breatnach F. Stallings RL, et al. Among authors: mcardle l. Cytogenet Genome Res. 2004;106(1):49-54. doi: 10.1159/000078560. Cytogenet Genome Res. 2004. PMID: 15218241

4

Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.

Gallagher WM, Bergin OE, Rafferty M, Kelly ZD, Nolan IM, Fox EJ, Culhane AC, McArdle L, Fraga MF, Hughes L, Currid CA, O'Mahony F, Byrne A, Murphy AA, Moss C, McDonnell S, Stallings RL, Plumb JA, Esteller M, Brown R, Dervan PA, Easty DJ. Gallagher WM, et al. Among authors: mcardle l. Carcinogenesis. 2005 Nov;26(11):1856-67. doi: 10.1093/carcin/bgi152. Epub 2005 Jun 15. Carcinogenesis. 2005. PMID: 15958521

5

High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.

Nair PN, McArdle L, Cornell J, Cohn SL, Stallings RL. Nair PN, et al. Among authors: mcardle l. Cancer Genet Cytogenet. 2007 Apr 15;174(2):100-10. doi: 10.1016/j.cancergencyto.2006.11.017. Cancer Genet Cytogenet. 2007. PMID: 17452250

6

Jugular pit associated with 5q14.3 deletion incorporating the MEF2C locus: a recurrent clinical finding.

Al-Shehhi M, Betts D, Mc Ardle L, Donoghue V, Reardon W. Al-Shehhi M, et al. Clin Dysmorphol. 2016 Jan;25(1):23-6. doi: 10.1097/MCD.0000000000000102. Clin Dysmorphol. 2016. PMID: 26426104 No abstract available.

7

Protein tyrosine phosphatase genes downregulated in melanoma.

McArdle L, Rafferty M, Maelandsmo GM, Bergin O, Farr CJ, Dervan PA, O'Loughlin S, Herlyn M, Easty DJ. McArdle L, et al. J Invest Dermatol. 2001 Nov;117(5):1255-60. doi: 10.1046/j.0022-202x.2001.01534.x. J Invest Dermatol. 2001. PMID: 11710941 Free article.

8

Tyrosine phosphate in melanoma progression.

McArdle L, Bergin O, Fallowfield ME, Dervan PA, Easty DJ. McArdle L, et al. Br J Dermatol. 2003 Aug;149(2):289-95. doi: 10.1046/j.1365-2133.2003.05405.x. Br J Dermatol. 2003. PMID: 12932234

9

Microarray analysis of phosphatase gene expression in human melanoma.

McArdle L, Rafferty MM, Satyamoorthy K, Maelandsmo GM, Dervan PA, Herlyn M, Easty DJ. McArdle L, et al. Br J Dermatol. 2005 May;152(5):925-30. doi: 10.1111/j.1365-2133.2005.06454.x. Br J Dermatol. 2005. PMID: 15888148

10

Nicolaides-Baraitser syndrome in a patient with hypertrophic cardiomyopathy and SMARCA2 gene deletion.

Foley R, Duignan S, McArdle L, Betts DR, Green A, McMahon CJ. Foley R, et al. Among authors: mcardle l. Cardiol Young. 2022 May;32(5):821-823. doi: 10.1017/S1047951121003826. Epub 2021 Sep 15. Cardiol Young. 2022. PMID: 34521483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page